Hospital Length of Stay and Impact of Readmission in the First 100 Days of Allogeneic Stem Cell Transplantation: Comparison Among Alternative Donor in Pediatric and Adult Population

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.401
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hematopoietic Stem Cell Transplantation Recipient and Caregiver Factors Affecting Length of Stay and Readmission

Oncology Nursing Forum
Oncology
2017English

Impact of Postpartum Hospital-Stay Legislation on Newborn Length of Stay, Readmission, and Mortality in California

Pediatrics
Child HealthPediatricsPerinatology
2006English

Length of Hospital Stay and Subsequent Emergency Readmission

BMJ
2005English

Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Psychosocial Adjustment of Pediatric Patients After Allogeneic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Cytomegalovirus Reactivation Is Associated With Increased Mortality More Than 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma

American Journal of Hematology
Hematology
2019English

Alternative Donor Sources for Hematopoietic Stem Cell Transplantation

2013English

Unrelated Donor Stem Cell Transplantation in Adult Patients With Thalassemia

Bone Marrow Transplantation
TransplantationHematology
2005English

Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Chronic Myelomonocytic Leukemia

Bone Marrow Transplantation
TransplantationHematology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy